Please login to the form below

Not currently logged in
Email:
Password:

New accounts: May

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period February to April 2005 inclusive.
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period February to April 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, e-mail nhobson@pmlive.com

AstraZeneca

Faslodex

Breast cancer

The Medical Multimedia Company

Genzyme

Thyrogen

Oncology

Big Blue

Genzyme Therapeutics

Corporate

Corporate

Langland

GlaxoSmithKline

New product

Neurology

Euro RSCG Life MSC

Intervet

Ibaflin gel

Antibiotic

Woolley Pau

Lilly

Corporate

Diabetes

PAN Advertising

Lilly

Humalog insulins and devices

Diabetes

PAN Advertising

Novartis

Zelnorm

IBS

The Medical Multimedia Company

Novo Nordisk

Diabetes insulin portfolio

Diabetes

Woolley Pau

Orion Pharma

Tridestra

HRT

Langland

Orion Pharma

Indivina

HRT

Langland

Roche

Avastin

Colorectal cancer

MJL Advertising

sanofi-aventis

Taxotere

Oncology

Medicus London

sanofi-aventis

Arava

Arthritis

Medicus London

sanofi-aventis

Targocid

Anti-infective

Medicus London

sanofi-aventis

Xatral

Benign prostatic hyperplasia

Medicus London

sanofi-aventis

Tavanic

Anti-infective

Medicus London

Schering-Plough

Subutex

Opioid dependence

Medicus London

Schering-Plough

Viraferon-Peg

Hepatitis C

Medicus London

Vernacare

Portfolio

Infection control

Mason Zimbler

2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics